CX3CL1 and lung adenocarcinoma: To overcome the challenging therapeutic schedule with recombinant FKN in mouse models, we overexpressed FKN directly from cancer cell lines, as observed for some human lung adenocarcinoma cell lines such as H358 and SW900 (Fig 2A).